Expression of CRH, CRH-related peptide and CRH receptor in the ovary and potential CRH signalling pathways

Journal of Reproductive Immunology

Volumn 90, Issue 1, 2011, Pages 67-73

  Wypior, Gabriela ^a   Jeschke, Udo ^a   Kurpisz, Maciej ^b   Szekeres Bartho, Julia ^c  

^a UNIVERSITY OF MUNICH   (Germany)

^b INSTITUTE OF HUMAN GENETICS   (Poland)

^c UNIVERSITY OF PÉCS   (Hungary)

Author keywords

CRH family; Ovary; Reproduction; Signal transduction

Indexed keywords

BINDING PROTEIN; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR; UROCORTIN;

ARTICLE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; NONHUMAN; OVARY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPRODUCTION; SIGNAL TRANSDUCTION; SWINE;

ANIMALS; CORTICOTROPIN-RELEASING HORMONE; FEMALE; HUMANS; OVARY; PEPTIDES; PREGNANCY; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; SIGNAL TRANSDUCTION; STRESS, PHYSIOLOGICAL;

EID: 79959980089     PISSN: 01650378     EISSN: 18727603     Source Type: Journal    
DOI: 10.1016/j.jri.2011.04.009     Document Type: Article

References (66)

1. Aguilera G., Harwood J.P., Wilson J.X., Morell J., Brown J.H., Catt K.J. Mechanisms of action of corticotropin-releasing factor and other regulators of corticotropin release in rat pituitary cells. J. Biol. Chem. 1983, 258:8039-8045.
2. Amweg A.N., Paredes A., Salvetti N.R., Lara H.E., Ortega H.H. Expression of melanocortin receptors mRNA, and direct effects of ACTH on steroid secretion in the bovine ovary. Theriogenology 2011, 75:628-637.
3. Arck P.C., Rucke M., Rose M., Szekeres-Bartho J., Douglas A.J., Pritsch M., et al. Early risk factors for miscarriage: a prospective cohort study in pregnant women. Reprod. Biomed. Online 2008, 17:101-113.
4. Asakura H., Zwain I.H., Yen S.S. Expression of genes encoding corticotropin-releasing factor (CRF), type 1 CRF receptor, and CRF-binding protein and localization of the gene products in the human ovary. J. Clin. Endocrinol. Metab. 1997, 82:2720-2725.
5. Bale T.L., Contarino A., Smith G.W., Chan R., Gold L.H., Sawchenko P.E., et al. Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behaviour and are hypersensitive to stress. Nat. Genet. 2000, 24:410-414.
6. Bamberger A.M., Minas V., Kalantaridou S.N., Radde J., Sadeghian H., Loning T., et al. Corticotropin-releasing hormone modulates human trophoblast invasion through carcinoembryonic antigen-related cell adhesion molecule-1 regulation. Am. J. Pathol. 2006, 168:141-150.
7. Behan D.P., De Souza E.B., Potter E., Sawchenko P., Lowry P.J., Vale W.W. Modulatory actions of corticotropin-releasing factor-binding protein. Ann. N. Y. Acad. Sci. 1996, 780:81-95.
8. Brar B.K., Chen A., Perrin M.H., Vale W. Specificity and regulation of extracellularly regulated kinase1/2 phosphorylation through corticotropin-releasing factor (CRF) receptors 1 and 2beta by the CRF/urocortin family of peptides. Endocrinology 2004, 145:1718-1729.
9. Brar B.K., Jonassen A.K., Stephanou A., Santilli G., Railson J., Knight R.A., et al. Urocortin protects against ischemic and reperfusion injury via a MAPK-dependent pathway. J. Biol. Chem. 2000, 275:8508-8514.
10. Calogero A.E., Burrello N., Negri-Cesi P., Papale L., Palumbo M.A., Cianci A., et al. Effects of corticotropin-releasing hormone on ovarian estrogen production in vitro. Endocrinology 1996, 137:4161-4166.
11. Claing A., Laporte S.A., Caron M.G., Lefkowitz R.J. Endocytosis of g protein-coupled receptors: roles of G protein-coupled receptor kinases and beta-arrestin proteins. Prog. Neurobiol. 2002, 66:61-79.
12. Coste S.C., Kesterson R.A., Heldwein K.A., Stevens S.L., Heard A.D., Hollis J.H., et al. Abnormal adaptations to stress and impaired cardiovascular function in mice lacking corticotropin-releasing hormone receptor-2. Nat. Genet. 2000, 24:403-409.
13. Coste S.C., Quintos R.F., Stenzel-Poore M.P. Corticotropin-releasing hormone-related peptides and receptors: emergent regulators of cardiovascular adaptations to stress. Trends Cardiovasc. Med. 2002, 12:176-182.
14. Dautzenberg F.M., Hauger R.L. The CRF peptide family and their receptors: yet more partners discovered. Trends Pharmacol. Sci. 2002, 23:71-77.
15. Donaldson C.J., Sutton S.W., Perrin M.H., Corrigan A.Z., Lewis K.A., Rivier J.E., et al. Cloning and characterization of human urocortin. Endocrinology 1996, 137:3896.
16. Erden H.F., Zwain I.H., Asakura H., Yen S.S. Corticotropin-releasing factor inhibits luteinizing hormone-stimulated p450c17 gene expression and androgen production by isolated thecal cells of human ovarian follicles. J. Clin. Endocrinol. Metab. 1998, 83:448-452.
17. Freedman N.J., Lefkowitz R.J. Desensitization of G protein-coupled receptors. Recent Prog. Horm. Res. 1996, 51:319-351. discussion 352-3.
18. Ghizzoni L., Mastorakos G., Vottero A., Barreca A., Furlini M., Cesarone A., et al. Corticotropin-releasing hormone (CRH) inhibits steroid biosynthesis by cultured human granulosa-lutein cells in a CRH and interleukin-1 receptor-mediated fashion. Endocrinology 1997, 138:4806-4811.
19. Grammatopoulos D.K., Randeva H.S., Levine M.A., Katsanou E.S., Hillhouse E.W. Urocortin, but not corticotropin-releasing hormone (CRH), activates the mitogen-activated protein kinase signal transduction pathway in human pregnant myometrium: an effect mediated via r1alpha and r2beta CRH receptor subtypes and stimulation of Gq-proteins. Mol. Endocrinol. 2000, 14:2076-2091.
20. Hatzoglou A., Margioris A.N., Bakogeorgou E., Gravanis A., Castanas E. Identification, characterization and localization of corticotropin-releasing hormone receptors in human placenta. Life Sci. 1996, 59:1871-1879.
21. Hauger R.L., Risbrough V., Brauns O., Dautzenberg F.M. Corticotropin releasing factor (CRF) receptor signaling in the central nervous system: new molecular targets. CNS Neurol. Disord. Drug Targets 2006, 5:453-479.
22. Hsu S.Y., Hsueh A.J. Human stresscopin and stresscopin-related peptide are selective ligands for the type 2 corticotropin-releasing hormone receptor. Nat. Med. 2001, 7:605-611.
23. Kalantaridou S.N., Makrigiannakis A., Mastorakos G., Chrousos G.P. Roles of reproductive corticotropin-releasing hormone. Ann. N. Y. Acad. Sci. 2003, 997:129-135.
24. Kalantaridou S.N., Zoumakis E., Makrigiannakis A., Godoy H., Chrousos G.P. The role of corticotropin-releasing hormone in blastocyst implantation and early fetal immunotolerance. Horm. Metab. Res. 2007, 39:474-477.
25. Kalantaridou S.N., Zoumakis E., Weil S., Lavasidis L.G., Chrousos G.P., Makrigiannakis A. Reproductive corticotropin releasing hormone, implantation, and fetal immunotolerance. Crit. Rev. Clin. Lab. Sci. 2007, 44:461-481.
26. Karteris E., Grammatopoulos D., Dai Y., Olah K.B., Ghobara T.B., Easton A., et al. The human placenta and fetal membranes express the corticotropin-releasing hormone receptor 1alpha (CRH-1alpha) and the CRH-c variant receptor. J. Clin. Endocrinol. Metab. 1998, 83:1376-1379.
27. Karteris E., Grammatopoulos D., Randeva H., Hillhouse E.W. Signal transduction characteristics of the corticotropin-releasing hormone receptors in the feto-placental unit. J. Clin. Endocrinol. Metab. 2000, 85:1989-1996.
28. Karteris E., Papadopoulou N., Grammatopoulos D.K., Hillhouse E.W. Expression and signalling characteristics of the corticotrophin-releasing hormone receptors during the implantation phase in the human endometrium. J. Mol. Endocrinol. 2004, 32:21-32.
29. Kishimoto T., Radulovic J., Radulovic M., Lin C.R., Schrick C., Hooshmand F., et al. Deletion of CRHR2 reveals an anxiolytic role for corticotropin-releasing hormone receptor-2. Nat. Genet. 2000, 24:415-419.
30. Lewis K., Li C., Perrin M.H., Blount A., Kunitake K., Donaldson C., et al. Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor. Proc. Natl. Acad. Sci. U.S.A. 2001, 98:7570-7575.
31. Lightman S.L. The neuroendocrinology of stress: a never ending story. J. Neuroendocrinol. 2008, 20:880-884.
32. Magiakou M.A., Mastorakos G., Webster E., Chrousos G.P. The hypothalamic-pituitary-adrenal axis and the female reproductive system. Ann. N. Y. Acad. Sci. 1997, 816:42-56.
33. Makrigiannakis A., Semmler M., Briese V., Eckerle H., Minas V., Mylonas I., et al. Maternal serum corticotropin-releasing hormone and acth levels as predictive markers of premature labor. Int. J. Gynaecol. Obstet. 2007, 97:115-119.
34. Makrigiannakis A., Zoumakis E., Margioris A.N., Theodoropoulos P., Stournaras C., Gravanis A. The corticotropin-releasing hormone (CRH) in normal and tumoral epithelial cells of human endometrium. J. Clin. Endocrinol. Metab. 1995, 80:185-189.
35. Mastorakos G., Scopa C.D., Kao L.C., Vryonidou A., Friedman T.C., Kattis D., et al. Presence of immunoreactive corticotropin-releasing hormone in human endometrium. J. Clin. Endocrinol. Metab. 1996, 81:1046-1050.
36. Mastorakos G., Scopa C.D., Vryonidou A., Friedman T.C., Kattis D., Phenekos C., et al. Presence of immunoreactive corticotropin-releasing hormone in normal and polycystic human ovaries. J. Clin. Endocrinol. Metab. 1994, 79:1191-1197.
37. Mastorakos G., Webster E.L., Friedman T.C., Chrousos G.P. Immunoreactive corticotropin-releasing hormone and its binding sites in the rat ovary. J. Clin. Invest. 1993, 92:961-968.
38. Mclean M., Bisits A., Davies J., Woods R., Lowry P., Smith R. A placental clock controlling the length of human pregnancy. Nat. Med. 1995, 1:460-463.
39. Minas V., Jeschke U., Kalantaridou S.N., Richter D.U., Reimer T., Mylonas I., et al. Abortion is associated with increased expression of fasl in decidual leukocytes and apoptosis of extravillous trophoblasts: a role for crh and urocortin. Mol. Hum. Reprod. 2007, 13:663-673.
40. Muramatsu Y., Sugino N., Suzuki T., Totsune K., Takahashi K., Tashiro A., et al. Urocortin and corticotropin-releasing factor receptor expression in normal cycling human ovaries. J. Clin. Endocrinol. Metab. 2001, 86:1362-1369.
41. Murase M., Uemura T., Kondoh Y., Funabashi T., Hirahara F. Role of corticotropin-releasing hormone in ovarian steroidogenesis. Endocrine 2002, 18:255-260.
42. Nakamura K., Sheps S., Arck P.C. Stress and reproductive failure: past notions, present insights and future directions. J. Assist. Reprod. Genet. 2008, 25:47-62.
43. Nappi R.E., Rivest S. Stress-induced genetic expression of a selective corticotropin-releasing factor-receptor subtype within the rat ovaries: an effect dependent on the ovulatory cycle. Biol. Reprod. 1995, 53:1417-1428.
44. O'keane V., Lightman S., Marsh M., Pawlby S., Papadopoulos A.S., Taylor A., et al. Increased pituitary-adrenal activation and shortened gestation in a sample of depressed pregnant women: a pilot study. J. Affect. Disord. 2011.
45. Olianas M.C., Lampis G., Onali P. Coupling of corticotropin-releasing hormone receptors to adenylyl cyclase in human y-79 retinoblastoma cells. J. Neurochem. 1995, 64:394-401.
46. Orth D.N., Mount C.D. Specific high-affinity binding protein for human corticotropin-releasing hormone in normal human plasma. Biochem. Biophys. Res. Commun. 1987, 143:411-417.
47. Perrin M., Donaldson C., Chen R., Blount A., Berggren T., Bilezikjian L., et al. Identification of a second corticotropin-releasing factor receptor gene and characterization of a cDNA expressed in heart. Proc. Natl. Acad. Sci. U.S.A. 1995, 92:2969-2973.
48. Pisarchik A., Slominski A.T. Alternative splicing of CRH-r1 receptors in human and mouse skin: identification of new variants and their differential expression. FASEB J. 2001, 15:2754-2756.
49. Reyes T.M., Lewis K., Perrin M.H., Kunitake K.S., Vaughan J., Arias C.A., et al. Urocortin II: a member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors. Proc. Natl. Acad. Sci. U.S.A. 2001, 98:2843-2848.
50. Rivier C., Brownstein M., Spiess J., Rivier J., Vale W. In vivo corticotropin-releasing factor-induced secretion of adrenocorticotropin, beta-endorphin, and corticosterone. Endocrinology 1982, 110:272-278.
51. Sakumoto R., Ito S., Komatsu T. Possible actions of corticotropin-releasing hormone in regulating porcine corpus luteum function. J. Vet. Med. Sci. 2010, 72:1173-1177.
52. Sasaki A., Shinkawa O., Yoshinaga K. Placental corticotropin-releasing hormone may be a stimulator of maternal pituitary adrenocorticotropic hormone secretion in humans. J. Clin. Invest. 1989, 84:1997-2001.
53. Seasholtz A.F., Valverde R.A., Denver R.J. Corticotropin-releasing hormone-binding protein: biochemistry and function from fishes to mammals. J. Endocrinol. 2002, 175:89-97.
54. Seres J., Bornstein S.R., Seres P., Willenberg H.S., Schulte K.M., Scherbaum W.A., et al. Corticotropin-releasing hormone system in human adipose tissue. J. Clin. Endocrinol. Metab. 2004, 89:965-970.
55. Smith G.W., Aubry J.M., Dellu F., Contarino A., Bilezikjian L.M., Gold L.H., et al. Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development. Neuron 1998, 20:1093-1102.
56. Teli T., Markovic D., Levine M.A., Hillhouse E.W., Grammatopoulos D.K. Regulation of corticotropin-releasing hormone receptor type 1alpha signaling: structural determinants for G protein-coupled receptor kinase-mediated phosphorylation and agonist-mediated desensitization. Mol. Endocrinol. 2005, 19:474-490.
57. Timpl P., Spanagel R., Sillaber I., Kresse A., Reul J.M., Stalla G.K., et al. Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor 1. Nat. Genet. 1998, 19:162-166.
58. Vale W., Spiess J., Rivier C., Rivier J. Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin. Science 1981, 213:1394-1397.
59. Van Pett K., Viau V., Bittencourt J.C., Chan R.K., Li H.Y., Arias C., et al. Distribution of mrnas encoding CRF receptors in brain and pituitary of rat and mouse. J. Comp. Neurol. 2000, 428:191-212.
60. Vaughan J., Donaldson C., Bittencourt J., Perrin M.H., Lewis K., Sutton S., et al. Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor. Nature 1995, 378:287-292.
61. Weninger S.C., Dunn A.J., Muglia L.J., Dikkes P., Miczek K.A., Swiergiel A.H., et al. Stress-induced behaviors require the corticotropin-releasing hormone (CRH) receptor, but not CRH. Proc. Natl. Acad. Sci. U.S.A. 1999, 96:8283-8288.
62. Xu J., Hennebold J.D., Stouffer R.L. Dynamic expression and regulation of the corticotropin-releasing hormone/urocortin-receptor-binding protein system in the primate ovary during the menstrual cycle. J. Clin. Endocrinol. Metab. 2006, 91:1544-1553.
63. Xu J., Xu F., Hennebold J.D., Molskness T.A., Stouffer R.L. Expression and role of the corticotropin-releasing hormone/urocortin-receptor-binding protein system in the primate corpus luteum during the menstrual cycle. Endocrinology 2007, 148:5385-5395.
64. Yata A., Nakabayashi K., Wakahashi S., Maruo N., Ohara N., Maruo T. Suppression of progesterone production by stresscopin/urocortin 3 in cultured human granulosa-lutein cells. Hum. Reprod. 2009, 24:1748-1753.
65. Zhong X.Y., Holzgreve W., Gebhardt S., Hillermann R., Tofa K.C., Gupta A.K., et al. Minimal alteration in the ratio of circulatory fetal DNA to fetal corticotropin-releasing hormone mRNA level in preeclampsia. Fetal Diagn. Ther. 2006, 21:246-249.
66. Zoumakis E., Chatzaki E., Charalampopoulos I., Margioris A.N., Angelakis E., Koumantakis E., et al. Cycle and age-related changes in corticotropin-releasing hormone levels in human endometrium and ovaries. Gynecol. Endocrinol. 2001, 15:98-102.